| NCT ID | NCT06859047 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Ospedale San Raffaele |
| Condition | Echocardiography, Transthoracic |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-01-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2023-01-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this prospective observational study is to assess the accuracy of non-invasive hemodynamic parameter estimation via trans-thoracic echocardiography (TTE) compared to the invasive gold standard of right heart catheterization (RHC). This study will include patients who undergo both TTE and RHC on the same day, under the same hemodynamic conditions. The primary research question is: how does the echodynamic evaluation perform compared to right heart catheterization?
Eligibility Criteria
Inclusion Criteria: * Clinical need for an invasive hemodynamic assessment and an echocardiographic evaluation on the same day Exclusion Criteria: * Incomplete hemodynamic assessment for any reason
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06859047 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Echocardiography, Transthoracic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06859047 currently recruiting?
Yes, NCT06859047 is actively recruiting participants. Contact the research team at gaspardone.carlo@hsr.it for enrollment information.
Where is the NCT06859047 trial being conducted?
This trial is being conducted at Bari, Italy, Milan, Italy, Pavia, Italy.
Who is sponsoring the NCT06859047 clinical trial?
NCT06859047 is sponsored by IRCCS Ospedale San Raffaele. The trial plans to enroll 200 participants.